meningococcal_prophylaxis
Table of Contents
meningococcal chemoprophylaxis
see also:
introduction
- contacts of patients with invasive meningococcal disease should be considered for contact tracing and chemoproprophylaxis.
- in addition, there are vaccines but these do not cover all subtypes
indications for chemoprophylaxis
- those who frequently ate, slept or stayed at the patient's home during the 7 days before the onset of symptoms, in particular, young children and their child caregivers or nursery-school contacts
- those who sat beside the patient on an airplane flight of 8 hours or longer
- those who had direct exposure to the patient through kissing, sharing utensils, drinking from same containers, etc
- those who may have performed mouth-to-mouth resuscitation
- doctors and nurses closely involved in intubation or other procedures involving patient's saliva or nasal secretions
- patients who only received benzyl penicillin as this does not eradicate nasal carriage
chemoprophylaxis options
- ceftriaxone 250 mg (child: 125 mg) IM, as a single dose (preferred option during pregnancy)
- OR
- ciprofloxacin (adult and child 12 years or more) 500 mg orally, as a single dose (preferred option for women taking oral contraceptives)
- OR
- rifampicin 600 mg (neonate: 5 mg/kg; child: 10 mg/kg up to 600 mg) orally, 12-hourly for 2 days (preferred option for children).
- rifampicin is associated with multiple drug interactions, including the combined oral contraceptive pill (OCP), and is contraindicated in pregnancy, alcoholism and severe liver disease.
- it will also stain contact lenses and cause the urine to go orange
meningococcal_prophylaxis.txt · Last modified: 2012/01/16 04:29 by 127.0.0.1